| SC 13G/A | 2024-02-14 | Point72 Asset Management, L.P. | Protagonist Therapeutics, Inc | 2,613,453 | 4.5% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Protagonist Therapeutics, Inc | 5,315,514 | 9.2% | EDGAR |
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Protagonist Therapeutics, Inc | 3,120,957 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Protagonist Therapeutics, Inc | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Protagonist Therapeutics, Inc | 3,153,916 | 5.5% | EDGAR |
| SC 13G/A | 2024-02-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Protagonist Therapeutics, Inc | 1,291,701 | 2.2% | EDGAR |
| SC 13G/A | 2024-02-02 | Farallon Capital Partners, L.P. | Protagonist Therapeutics, Inc | 386,653 | 0.7% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Protagonist Therapeutics, Inc | 5,543,902 | 9.6% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Protagonist Therapeutics, Inc | - | 4.7% | EDGAR |
| SC 13G | 2023-12-18 | Point72 Asset Management, L.P. | Protagonist Therapeutics, Inc | 3,186,077 | 5.5% | EDGAR |
| SC 13G | 2023-04-13 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Protagonist Therapeutics, Inc | 2,955,000 | 5.4% | EDGAR |
| SC 13G | 2023-03-20 | BIOTECHNOLOGY VALUE FUND L P | Protagonist Therapeutics, Inc | 2,630,650 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Protagonist Therapeutics, Inc | 316,500 | 0.6% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | Protagonist Therapeutics, Inc | 3,591,986 | 7.3% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Protagonist Therapeutics, Inc | 577,541 | 1.2% | EDGAR |
| SC 13G/A | 2023-02-09 | Farallon Capital Partners, L.P. | Protagonist Therapeutics, Inc | 601,195 | 1.2% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | Protagonist Therapeutics, Inc | 3,097,714 | 6.3% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | Protagonist Therapeutics, Inc | 3,652,157 | 7.4% | EDGAR |
| SC 13G/A | 2023-01-11 | JOHNSON & JOHNSON | Protagonist Therapeutics, Inc | 2,449,183 | 5.0% | EDGAR |
| SC 13G/A | 2023-01-10 | STATE STREET CORP | Protagonist Therapeutics, Inc | - | 7.7% | EDGAR |